Biotech

All Articles

Arrowhead fires off phase 3 records in unusual metabolic illness ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its hand in front of a possible face-off with Ionis, releasi...

Pfizer, Valneva show lyme ailment go reliable for second booster

.Pfizer as well as Valneva might have regarding pair of even more years to stand by just before they...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Allow's study a conversation with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz as...

New information demonstrate how Bayer's asundexian neglected to stop strokes

.Bayer put on hold the phase 3 trial for its own element XIa prevention asundexian late in 2014 afte...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its several sclerosis (MS) med tolebrutinib to the FDA, execs have...

Galapagos' stockpile as fund reveals intent to mold its own progression

.Galapagos is happening under added pressure from investors. Having developed a 9.9% concern in Gala...

Cell- concentrated Sana scoops initial CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Allist pays off Jacobio $21M, landing part in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually purchased on its own a starring job in China's KRAS ma...

ReNeuron leaving behind AIM substitution after overlooking fundraising goal

.ReNeuron has actually signed up with the long list of biotechs to leave behind Greater london's int...

MBX apply for IPO to take challenger to Ascendis in to phase 3

.MBX Biosciences has included in the current outbreak of IPO filings. The biotech, which submitted i...